• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, October 8, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Lower incidence of esophagitis in elderly NSCLC patients undergoing definitive radiation

Bioengineer by Bioengineer
February 1, 2017
in Science News
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

DENVER – Elderly non-small cell lung cancer (NSCLC) patients undergoing definitive radiation have a lower incidence of esophagitis compared to younger patients and tolerate aggressive standard treatment regimens.

Lung cancer is the leading cause of cancer deaths worldwide, causing more deaths than breast, colon, and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for roughly 85% of lung cancers. A large proportion of patients with lung cancer are elderly, over the age of 65, and are often poorly represented in clinical trials, undertreated, or don't receive aggressive standard treatment due to concerns about their ability to tolerate aggressive treatment regimens. While elderly patients are not different than younger patients in their willingness to accept aggressive treatment, even elderly patients with good performance status and lack of comorbidities are less likely than younger patients to be offered aggressive treatments on the basis of age. Radiotherapy is the standard treatment regimen for locally advanced NSCLC, but can lead to esophagitis and radiation pneumonitis, which are potentially life-altering toxicities of thoracic radiation.

A group of researchers in the United States conducted a study to evaluate elderly patients undergoing definitive lung radiation to assess how the elderly tolerate treatment compared to younger patients. Patients undergoing definitive radiation for lung cancer with or without chemotherapy from 2004-2013 were identified from a prospective institutional database in which patients of all ages were eligible for inclusion (UM cohort). Patients were excluded if they were treated with stereotactic body radiation therapy (SBRT) or if complete dosimetric information was not available for review. Logistic regression modeling was performed to assess the impact of age on esophagitis grade ?3 or ?2 and pneumonitis grade ?3 or ?2, adjusting for esophageal and lung dose, chemotherapy utilization, smoking status, and performance status. The analysis was validated in a large cohort of 691 patients from the Michigan Radiation Oncology Quality Consortium (MROQC) registry, an independent state-wide prospective database.

The results of the study published in the Journal of Thoracic Oncology, the official journal of the International Association for the Study of Lung Cancer (IASLC), reported that there were 179 patients extracted from the UM cohort, of which, after exclusions, 125 patients with lung cancer were included in the analysis. The median age in the UM cohort was 66, with 34% of the patients older than 70. Among the 125 patients in the UM cohort, 49 (39%) experienced grade ?2 and 14 (11%) experienced grade ?3 esophagitis. Of the 125 patients, 82 patients were

The authors comment that, "Our study demonstrates significantly decreased incidence of radiation esophagitis in elderly patients. This finding remained significant even after adjusting for esophageal dose, concurrent chemotherapy, history of smoking, and performance status. In patients who are never smokers with good performance status, who received high doses of radiation to the esophagus with concurrent chemotherapy, the probability of esophagitis for a 70 year old is approximately one-third that of an identical 50 year old patient. Pattern of care studies suggest that the elderly are being undertreated for various malignancies including lung cancer, independent of other variables including performance status. Our study undermines this practice and supports standard definitive treatment for the elderly with good performance status."

###

Co-authors Feng-Ming Kong, James A. Hayman, and Gregory P. Kalemkerian are members of IASLC.

About the IASLC

The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated to the study of lung cancer. Founded in 1974, the association's membership includes more than 5,000 lung cancer specialists in over 100 countries. Visit http://www.iaslc.org for more information.

Written by: Jacinta Wiens, PhD, 720-598-1941; [email protected]

Media Contact: Becky Bunn, 720-254-9509; [email protected]

Media Contact

Becky Bunn
[email protected]
720-325-2946

http://iaslc.org/

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

How Breastfeeding Boosts Babies’ Immunity: New Discoveries Unveiled

October 8, 2025

AI Mimics Pathologists for Clear Prostate Cancer Grading

October 8, 2025

Dual HDAC/PI3K Inhibitors Trigger Apoptosis in p53-Mutant Lymphoma

October 8, 2025

SnO₂-SiO₂ Nanotube Composites Enhance Lithium-Ion Battery Stability

October 8, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1091 shares
    Share 436 Tweet 273
  • New Study Reveals the Science Behind Exercise and Weight Loss

    100 shares
    Share 40 Tweet 25
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    95 shares
    Share 38 Tweet 24
  • Ohio State Study Reveals Protein Quality Control Breakdown as Key Factor in Cancer Immunotherapy Failure

    79 shares
    Share 32 Tweet 20

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

How Breastfeeding Boosts Babies’ Immunity: New Discoveries Unveiled

AI Mimics Pathologists for Clear Prostate Cancer Grading

Dual HDAC/PI3K Inhibitors Trigger Apoptosis in p53-Mutant Lymphoma

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 62 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.